High degree of nonadherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.

J Rheumatol

From the Department of Internal Medicine 3 and the Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.V. Rauscher, Medical Student; M. Englbrecht, Dipl.-Psych. Univ.; G. Schett, MD, Professor; A.J. Hueber, MD, PhD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; D. van der Heijde, MD, Professor, Department of Rheumatology, Leiden University Medical Center.

Published: March 2015